Last Price
1.00
Today's Change
+0.625 (164.47%)
Day's Change
0.743 - 1.31
Trading Volume
223,832,092
Profile
TVGN
Exchange: NASDAQ Global Market NASDAQ Global Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Ryan H. Saadi M.D., M.P.H, M.P.H. Dr. Ryan H. Saadi M.D., M.P.H, M.P.H.
Full Time Employees: 17 17
IPO Date: 2022-01-05 2022-01-05
CIK: 0001860871 0001860871
ISIN: US88165K1016 US88165K1016
Beta: 0.31 0.31
Last Dividend: 0.00 0.00
Dcf Diff: 1.05 1.05
Dcf: -0.01 -0.01
Description
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
Uniqlo Owner Targets Higher Sales From Strong Western Market
2
CEO Morning Brief
3
4
CEO Morning Brief
5
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
